Lingyun Xu

1.1k total citations
42 papers, 864 citations indexed

About

Lingyun Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lingyun Xu has authored 42 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Lingyun Xu's work include Cancer-related molecular mechanisms research (5 papers), Immunotherapy and Immune Responses (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Lingyun Xu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Immunotherapy and Immune Responses (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Lingyun Xu collaborates with scholars based in China, United States and South Korea. Lingyun Xu's co-authors include Sanjiv S. Gambhir, Arutselvan Natarajan, Yulan Zhu, Jacob Gano, Aaron T. Mayer, Robert E. Reeves, Lanfang Cao, Qi Qian, Wei‐xian Chen and Lin Cheng and has published in prestigious journals such as PLoS ONE, Small and The Journal of Infectious Diseases.

In The Last Decade

Lingyun Xu

35 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyun Xu China 15 281 257 239 170 119 42 864
Geoffrey Seidel United States 8 221 0.8× 223 0.9× 392 1.6× 95 0.6× 112 0.9× 14 1.0k
Bashir M. Mohamed Ireland 16 223 0.8× 148 0.6× 252 1.1× 116 0.7× 79 0.7× 30 914
Tamer Refaat United States 12 395 1.4× 142 0.6× 484 2.0× 75 0.4× 152 1.3× 42 1.1k
Zhiyang Zhou China 22 308 1.1× 469 1.8× 230 1.0× 155 0.9× 193 1.6× 80 1.3k
Xiaofang Guo China 19 290 1.0× 215 0.8× 109 0.5× 196 1.2× 106 0.9× 56 916
Yuanji Xu China 17 377 1.3× 211 0.8× 130 0.5× 210 1.2× 98 0.8× 70 893
Nobutaka Iwakuma Japan 16 171 0.6× 217 0.8× 382 1.6× 92 0.5× 74 0.6× 42 872
Brian Wan-Chi Tse Australia 13 210 0.7× 118 0.5× 414 1.7× 58 0.3× 169 1.4× 24 822
Sung Hwan Lee South Korea 16 199 0.7× 418 1.6× 70 0.3× 140 0.8× 203 1.7× 80 908
Jihyoun Lee South Korea 12 152 0.5× 199 0.8× 217 0.9× 76 0.4× 185 1.6× 35 760

Countries citing papers authored by Lingyun Xu

Since Specialization
Citations

This map shows the geographic impact of Lingyun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Xu more than expected).

Fields of papers citing papers by Lingyun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Xu. The network helps show where Lingyun Xu may publish in the future.

Co-authorship network of co-authors of Lingyun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Xu. A scholar is included among the top collaborators of Lingyun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Xu. Lingyun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Lingyun, Yujie Tang, Ting Zhang, et al.. (2025). Association Analysis of Insulin Resistance Metabolic Score (METS‐IR) and Gestational Diabetes Mellitus: Based on National Health and Nutrition Examination Survey Database From 2007 to 2018. Endocrinology Diabetes & Metabolism. 8(4). e70062–e70062. 1 indexed citations
2.
Yang, Xueyan, Yu‐Xin Tian, Xidong Li, et al.. (2025). Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B. Hepatology International. 19(4). 796–808.
3.
Yang, Xueyan, Xidong Li, Qiao Yang, et al.. (2025). A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study. The Journal of Infectious Diseases. 232(2). 485–498.
4.
5.
Sun, Junyi, et al.. (2024). Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation. Stem Cell Research. 81. 103527–103527. 2 indexed citations
6.
Xu, Lingyun, et al.. (2023). Prognostic significance of HALP score and combination of peripheral blood multiple indicators in patients with early breast cancer. Frontiers in Oncology. 13. 1253895–1253895. 9 indexed citations
7.
Chen, Weiyu, Lingyun Xu, Edwin Chang, et al.. (2022). Alternative medicine: therapeutic effects on gastric original signet ring carcinoma via ascorbate and combination with sodium alpha lipoate. BMC Complementary Medicine and Therapies. 22(1). 58–58. 1 indexed citations
8.
Xiao, Mei, Yue Han, Juan Liu, et al.. (2022). Preparation of hollow mesoporous prussian blue coated with mesoporous silica shell nanocubes for photothermal therapy and drug carrier. Materials Letters. 312. 131697–131697. 5 indexed citations
9.
Wang, Weiguo, Lingyun Xu, Miao Zhang, et al.. (2021). Multiple osteolytic primary peripheral T-cell bone lymphoma: the first case report. Journal of International Medical Research. 49(10). 3619113157–3619113157.
10.
Cheng, Lin, Xu Zhang, Yuzhou Huang, et al.. (2021). Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway. Oncogenesis. 10(1). 7–7. 61 indexed citations
11.
Li, Deling, Qiang Liu, Qingrong Qi, et al.. (2020). Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones. Small. 16(43). e2003851–e2003851. 135 indexed citations
12.
Xu, Lingyun, Jung‐Rok Lee, Shiying Hao, et al.. (2019). Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies. PLoS ONE. 14(8). e0221051–e0221051. 22 indexed citations
13.
Chen, Wei‐xian, Lin Cheng, Qi Qian, et al.. (2019). Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer. Oncology Letters. 18(6). 6017–6025. 18 indexed citations
14.
Chen, Wei‐xian, Lingyun Xu, Qi Qian, et al.. (2018). d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission. Bioscience Reports. 38(5). 19 indexed citations
15.
Xu, Lingyun, et al.. (2018). Effectiveness of acupuncture in the management of cervical spondylosis: a meta-analysis.. PubMed. 31(4). 1017–1022. 6 indexed citations
16.
Zhang, Chao, Richard H. Kimura, Lotfi Abou‐Elkacem, et al.. (2016). A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects. Journal of Nuclear Medicine. 57(10). 1629–1634. 20 indexed citations
17.
Lu, Yanming, et al.. (2016). Short-term association between particular matter air pollution and pediatric clinical visits for wheezing in a subarea of Shanghai. Environmental Science and Pollution Research. 23(19). 19201–19211. 9 indexed citations
18.
Xu, Lingyun, et al.. (2015). Bacterial Lysate Increases the Percentage of Natural Killer T Cells in Peripheral Blood and Alleviates Asthma in Children. Pharmacology. 95(3-4). 139–144. 37 indexed citations
19.
Lu, Yanming, Lingyun Xu, Min Xia, Yaqin Li, & Lanfang Cao. (2014). The Efficacy and Safety of Subcutaneous Immunotherapy in Mite-Sensitized Subjects With Asthma: A Meta-Analysis. Respiratory Care. 60(2). 269–278. 25 indexed citations
20.
Xu, Lingyun & Lanfang Cao. (2013). GSTT1 genetic polymorphism and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis. Tumor Biology. 35(2). 1433–1437. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey Seidel Breakdown of academic impact, for papers by Bashir M. Mohamed Breakdown of academic impact, for papers by Tamer Refaat Breakdown of academic impact, for papers by Zhiyang Zhou Breakdown of academic impact, for papers by Xiaofang Guo Breakdown of academic impact, for papers by Yuanji Xu Breakdown of academic impact, for papers by Nobutaka Iwakuma Breakdown of academic impact, for papers by Brian Wan-Chi Tse Breakdown of academic impact, for papers by Sung Hwan Lee Breakdown of academic impact, for papers by Jihyoun Lee
Rankless by CCL
2026